Pharmacological influences of natural products as bioenhancers of silymarin against carbon tetrachloride-induced hepatotoxicity in rats
暂无分享,去创建一个
[1] K. Kohli,et al. Solubility and Dissolution Enhancement of Silymarin with Fulvic Acid Carrier , 2016 .
[2] K. Kohli,et al. THE CONCEPT OF BIOENHANCERS IN BIOAVAILABILITY ENHANCEMENT OF DRUGS – A PATENT REVIEW , 2016 .
[3] K. Kohli,et al. Solubility and Dissolution Enhancement of Silymarin with Fulvic AcidCarrier , 2016 .
[4] J. Ejiofor,et al. Pharmacological evaluation of Ipomoea asarifolia (Desr.) against carbon tetrachloride-induced hepatotoxicity in rats. , 2012, Journal of ethnopharmacology.
[5] A. N. Kişioğlu,et al. EFFECT OF SILYBUM MARIANUM ON ACUTE HEPATIC DAMAGE CAUSED BY CARBON TETRACHLORIDE IN RATS , 2012 .
[6] E. Youness,et al. Potential Effect Of Garlic Oil and Silymarin on Carbon Tetrachloride-Induced Liver Injury , 2012 .
[7] Mushir M. Ali,et al. Reassessing bioavailability of silymarin. , 2011, Alternative medicine review : a journal of clinical therapeutic.
[8] U. Patil,et al. Role of Piperine As A Bioavailability Enhancer , 2011 .
[9] J. Pedraza,et al. Antioxidant activity of fulvic acid: A living matter-derived bioactive compound , 2011 .
[10] W. Zong,et al. Anti-hepatotoxic and anti-oxidant effects of extracts from Piper nigrum L. root , 2011 .
[11] P. Mathi,et al. Hepatoprotectivity and an Antioxidant Study of Ipomoea hederacea on Experimentally Induced Hepatotoxic Rats , 2010 .
[12] K. Bedi,et al. Bioenhancers: Revolutionary concept to market. , 2010 .
[13] E. Shaker,et al. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[14] J. Patel,et al. Hepatoprotective activity of Piper longum traditional milk extract on carbon tetrachloride induced liver toxicity in Wistar rats , 2009 .
[15] K. Shanker,et al. Synergistic effect of silymarin and standardized extract of Phyllanthus amarus against CCl4-induced hepatotoxicity in Rattus norvegicus. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[16] Y. Hsieh,et al. Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats , 2008, Journal of viral hepatitis.
[17] C. Pouton,et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.
[18] P. Muriel,et al. Beneficial drugs for liver diseases , 2008, Journal of applied toxicology : JAT.
[19] Lie-Chwen Lin,et al. Hepatobiliary Excretion of Silibinin in Normal and Liver Cirrhotic Rats , 2008, Drug Metabolism and Disposition.
[20] Lie-Chwen Lin,et al. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. , 2007, Journal of pharmaceutical and biomedical analysis.
[21] L. Radko,et al. Application of silymarin in human and animal medicine , 2007 .
[22] C. Girish,et al. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. , 2006, The Indian journal of medical research.
[23] Roger Williams. Global challenges in liver disease , 2006, Hepatology.
[24] E. Mahmoud,et al. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. , 2006, International journal of pharmaceutics.
[25] V. Křen,et al. Silybin and silymarin--new effects and applications. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[26] O. Katare,et al. Comparative study of different silymarin formulations: formulation, characterisation and in vitro/in vivo evaluation. , 2005, Current drug delivery.
[27] A. El-Gendy,et al. Evaluation of silymarin and / or ginger effect on induced hepatotoxicity by carbon tetrachloride in male albino rats , 2003 .
[28] M. Hashizume,et al. A Long‐term Follow‐up Study on Risk Factors for Hepatocellular Carcinoma among Japanese Patients with Liver Cirrhosis , 1998, Japanese journal of cancer research : Gann.
[29] A. J. Gandolfi,et al. Novel mechanisms in chemically induced hepatotoxicity 1 , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] P. Muriel,et al. Prevention by silymarin of membrane alterations in acute CCI4 liver damage , 1990, Journal of applied toxicology : JAT.
[31] G. Clawson. Mechanisms of carbon tetrachloride hepatotoxicity. , 1989, Pathology and immunopathology research.
[32] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[33] J. Castro,et al. Prevention of carbon tetrachloride-induced necrosis by inhibitors of drug metabolism--further studies on their mechanism of action. , 1974, Biochemical pharmacology.
[34] K. Aterman. Toxic effect of carbon tetrachloride on the liver cell. , 1962, British journal of pharmacology and chemotherapy.